Early Stage Breast Cancer Clinical Trials in New Brunswick, New Jersey
2 recruitingNew Brunswick, New Jersey
Showing 1–2 of 2 trials
Recruiting
Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+8 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting
Phase 2
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Early Stage Breast CancerCardiac Toxicity
Rutgers, The State University of New Jersey60 enrolled10 locationsNCT05559164